Dr Sherman S Wiggins, MD | |
1453 E Bert Koun Loop Ste 112, Shreveport, LA 71105-6810 | |
(318) 798-9400 | |
(318) 795-4656 |
Full Name | Dr Sherman S Wiggins |
---|---|
Gender | Male |
Speciality | Cardiac Electrophysiology |
Experience | 38 Years |
Location | 1453 E Bert Koun Loop Ste 112, Shreveport, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063402717 | NPI | - | NPPES |
127235001 | Medicaid | AR | |
1973807 | Medicaid | LA | |
060021052 | Other | LA | RAILROAD MEDICARE |
107224101 | Medicaid | TX |
Facility Name | Location | Facility Type |
---|---|---|
Christus Health Shreveport - Bossier | Shreveport, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Advanced Cardiovascular Specialists | 7315224755 | 20 |
News Archive
Plastic surgeons have long debated the mechanisms aging-related changes in the face: Are they related more to "deflation" or "sagging"? A new study helps settle the debate, showing significant loss of volume in the upper lip in older adults, reports the February issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
Veracyte, Inc., a molecular diagnostics company that is pioneering the emerging field of molecular cytology, today announced results from a large, prospective, multicenter study, which demonstrated the potential for the Afirma® Gene Expression Classifier, a gene expression test, to reduce the large number of unnecessary surgeries in thyroid cancer diagnosis by more than half.
Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a new combination of drugs.
› Verified 3 days ago
Entity Name | Advanced Cardiovascular Specialists |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881127090 PECOS PAC ID: 7315224755 Enrollment ID: O20170512002294 |
News Archive
Plastic surgeons have long debated the mechanisms aging-related changes in the face: Are they related more to "deflation" or "sagging"? A new study helps settle the debate, showing significant loss of volume in the upper lip in older adults, reports the February issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
Veracyte, Inc., a molecular diagnostics company that is pioneering the emerging field of molecular cytology, today announced results from a large, prospective, multicenter study, which demonstrated the potential for the Afirma® Gene Expression Classifier, a gene expression test, to reduce the large number of unnecessary surgeries in thyroid cancer diagnosis by more than half.
Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a new combination of drugs.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Sherman S Wiggins, MD Po Box 51008, Shreveport, LA 71135-1008 Ph: (318) 798-9400 | Dr Sherman S Wiggins, MD 1453 E Bert Koun Loop Ste 112, Shreveport, LA 71105-6810 Ph: (318) 798-9400 |
News Archive
Plastic surgeons have long debated the mechanisms aging-related changes in the face: Are they related more to "deflation" or "sagging"? A new study helps settle the debate, showing significant loss of volume in the upper lip in older adults, reports the February issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
Veracyte, Inc., a molecular diagnostics company that is pioneering the emerging field of molecular cytology, today announced results from a large, prospective, multicenter study, which demonstrated the potential for the Afirma® Gene Expression Classifier, a gene expression test, to reduce the large number of unnecessary surgeries in thyroid cancer diagnosis by more than half.
Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a new combination of drugs.
› Verified 3 days ago
Mansi Shah, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1455 E Bert Koun Loop, #210, Shreveport, LA 71105 Phone: 318-798-4515 Fax: 318-798-4530 | |
Pratik Agrawal, Internal Medicine Medicare: Medicare Enrolled Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
Dr. Bader Alotaibi, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2727 Hearne Ave Ste 301, Shreveport, LA 71103 Phone: 318-631-6400 | |
Paul A Rushing, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1455 E Bert Kouns Loop, Shreveport, LA 71105 Phone: 318-798-4488 Fax: 318-798-4420 | |
Sanjay Jain, Internal Medicine Medicare: Medicare Enrolled Practice Location: 510 E Stoner Ave, Primary Care (110), Shreveport, LA 71101 Phone: 318-221-8411 | |
Steven R Bailey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
Venkateswara K Rao, M.D., Internal Medicine Medicare: Medicare Enrolled Practice Location: 1501 Kings Hwy, Department Of Medicine, Shreveport, LA 71103 Phone: 318-675-5000 |